Mia's Feed
Medical News & Research

Innovative Pen-Like Device for Rapid Detection of Opioids via Skin Analysis

Innovative Pen-Like Device for Rapid Detection of Opioids via Skin Analysis

Share this article

A novel pen-shaped device offers rapid, non-invasive detection of opioids from the skin using mass spectrometry, promising to enhance overdose screening and intervention efforts.

2 min read

A groundbreaking technological advancement presented in boratory Analytical Chemistryids in the fight against opioid overdose crises. Researchers have developed a portable, pen-shaped device capable of quickly and non-invasively extracting and analyzing molecules from the skin's surface to detect opioid substances, such as fentanyl, morphine, and oxycodone.

Opioids are the primary drugs associated with overdose fatalities in the United States, often detected through blood, saliva, or urine tests, which can be time-consuming and require laboratory processing. This new tool, inspired by the clinical MasSpec Pen technology used in cancer tissue analysis, offers a rapid alternative by directly sampling the skin.

The modified MasSpec Pen works by depositing a tiny droplet of water and ethanol onto the skin, which then collects molecules indicative of opioid use over a span of just three seconds. The collected sample is immediately aspirated into a collection vial and can be analyzed on-site using mass spectrometry highly sensitive method for molecular detection. If needed, samples can also be stored for later examination.

Initial testing demonstrated promising results. When applied to volunteers with known opioid exposure, the device detected fentanyl in seven out of eight skin samples, compared to its presence in all urine samples and in some saliva samples. Although the detection levels from skin samples were lower than traditional biological fluids, the device's ease of use and portability highlight its potential for field or clinical applications.

The researchers acknowledge factors such as skin type, cleanliness, and timing of drug intake may influence results and plan further studies to optimize detection limits and expand understanding. Some of the team members hold patents related to the MasSpec Pen and are involved in commercializing this technology.

This development could enable earlier interventions for individuals at risk of overdose or requiring substance use treatment, providing a quick, non-invasive, and accessible screening method outside traditional laboratory settings.

Source: https://medicalxpress.com/news/2025-06-handy-pen-tool-opioids-skin.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Comprehensive Prehabilitation Strategy Benefits Frail Heart Failure Patients Awaiting Surgery

A multidisciplinary prehabilitation protocol significantly improves physical and cognitive health in frail heart failure patients awaiting surgery, enhancing surgical outcomes and recovery prospects.

Elon Musk's Neuralink Implant Restores Movement in Paralyzed Veteran During Clinical Trial

A paralyzed veteran receives Neuralink's brain chip in a pioneering clinical trial, restoring movement and control over electronic devices, marking a major breakthrough in neurotechnology.

The True Cost of Dementia: Unpaid Care Falling on Family and Friends Reaches $224 Billion

Family and friends provide unpaid care for dementia patients, totaling an estimated $224 billion annually in the U.S., revealing substantial regional disparities and highlighting the need for better caregiver support.

'Rogue' immune cells may explain why some celiac patients do not recover on a gluten-free diet

New research reveals that mutated 'rogue' immune cells in the gut may cause persistent symptoms in some celiac patients despite gluten avoidance. Advanced genomic studies are opening the door to targeted treatments for refractory celiac disease.